Nukkleus Inc. Files 8-K for Material Agreement
Ticker: DFNSW · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1787518
Sentiment: neutral
Topics: material-agreement, filing-update, corporate-action
Related Tickers: NUKK
TL;DR
NUKK filed an 8-K for a material agreement as of Sept 30. Check for details.
AI Summary
Nukkleus Inc. filed an 8-K on October 4, 2024, reporting on a material definitive agreement entered into as of September 30, 2024. The filing also includes financial statements and exhibits. The company, formerly Brilliant Acquisition Corp., is incorporated in Delaware and its fiscal year ends on September 30.
Why It Matters
This filing indicates a significant business development or contractual agreement for Nukkleus Inc., which could impact its operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood by the market.
Key Numbers
- 001-39341 — SEC File Number (Identifies the company's filing history with the SEC.)
- 38-3912845 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Nukkleus Inc. (company) — Registrant
- Brilliant Acquisition Corp. (company) — Former company name
- September 30, 2024 (date) — Date of earliest event reported
- October 4, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement reported?
The filing indicates the entry into a material definitive agreement as of September 30, 2024, but the specific details of the agreement are not provided in this excerpt.
When was this 8-K filing submitted to the SEC?
The filing was submitted on October 4, 2024.
What was Nukkleus Inc.'s former name?
Nukkleus Inc.'s former name was Brilliant Acquisition Corp.
In which state is Nukkleus Inc. incorporated?
Nukkleus Inc. is incorporated in Delaware.
What is the company's fiscal year end date?
The company's fiscal year ends on September 30.
Filing Stats: 581 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-10-04 16:30:12
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
- $11.50 — sable for one Share of Common Stock for $11.50 per share NUKKW The Nasdaq Stock Ma
Filing Documents
- ea0216612-8k_nukkleus.htm (8-K) — 29KB
- ea021661201ex10-1_nukkleus.htm (EX-10.1) — 14KB
- 0001213900-24-085585.txt ( ) — 259KB
- nukk-20240930.xsd (EX-101.SCH) — 4KB
- nukk-20240930_def.xml (EX-101.DEF) — 26KB
- nukk-20240930_lab.xml (EX-101.LAB) — 36KB
- nukk-20240930_pre.xml (EX-101.PRE) — 25KB
- ea0216612-8k_nukkleus_htm.xml (XML) — 6KB
01
Item 1.01. Entry Into a Material Definitive Agreement. On September 30, 2024, Nukkleus Inc. (the "Company"), Triton Capital Markets Ltd. ("TCM") and FXDirectDealer LLC ("FXDD") entered into a Release Agreement pursuant to which the parties confirmed that the General Services Agreement dated May 24, 2016, as amended ("GSA") between the Company and TCM and the General Services Agreement dated May 24, 2016, as amended ("FXDD GSA") between the Company and FDDD were terminated effective January 1, 2024. The parties further confirmed that there are no obligations or liabilities outstanding or owed between the parties as of September 30, 2024 and each party released and forever discharged the other party from any and all claims, demands, damages, actions, causes of action, or suits of any kind or nature whatsoever, both known and unknown, which have arisen or may arise from the GSA or the FXDD GSA The foregoing description of the Release Agreement is not complete and is qualified in its entirety by reference to the Release Agreement, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits Exhibit No. Exhibit Description 10.1 Release Agreement between Nukkleus Inc., Triton Capital Markets Ltd. and FXDirectDealer LLC dated September 30, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: October 4, 2024 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 2